This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

5 S&P 500 Stocks Poised for Stellar 2013 Sales Growth

Stocks in this article: COG LEN ALXN AMZN DVA

With every passing year, Amazon pulls out a fresh growth initiative that manages to tack on more revenues to the income statement. Back in the last decade, Amazon's sales grew an impressive $3 to $4 billion annually. More recently, sales shot up $10 billion in 2010 (to $34 billion), $14 billion in 2011, and are projected to grow at a similar pace in both 2012 and 2013. How many other companies can pull off that kind of growth without resorting to acquisitions? Only Apple ( AAPL) and Google ( GOOG) can make a similar claim.

Still, it's far to wonder when Jeff Bezos will start to pay attention to the bottom line as well. Amazon has never earned more than $2.50 a share in any given year in its existence, and that's unlikely to happen in 2012 or 2013 either. At some point, this $250 stock will have to morph into a really impressive profit growth story for shares to scale new heights.

DVita Healthcare

Projected 2013 sales growth: 26%

This is fast-becoming one of Warren Buffet's favorite stocks. His investment firm, Berkshire Hathaway ( BRK), has been acquiring roughly one million shares a month and speculation has risen that Berkshire might eventually expand its current 13% stake to 100%.

You can understand the appeal. This operator of 1,900 dialysis clinics is a steady grower that throws off ample cash. Free cash flow has steadily risen from $300 million in 2008 to roughly $780 million in 2011, and should exceed $1 billion by 2013.

Still, investors need to be aware of the cost pressures on healthcare as they assess an investment in DaVita ( DVA).

The company currently bills Medicare and Medicaid an average of $88,000 per patient, and the total national tab now exceeds $30 billion. You can be sure the government will seek to drum some savings out of Medicare and Medicaid as the Federal budget tightens, and Davita will have to lobby hard to be sure that it's reimbursement rates don't get trimmed.

To see these stocks in action, visit the 5 S&P 500 stocks poised for stellar sales growth in 2013 portfolio.

3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs